XML 31 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes
9 Months Ended
Aug. 23, 2020
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
On March 27, 2020, the CARES Act was signed into law in the United States. The CARES Act includes certain provisions that affect income taxes, including temporary five-year net operating loss carryback provisions and a modification of interest deduction limitations.
The Company's effective income tax rate for the three months ended August 23, 2020 was 47.6% and reflects a $24.6 million income tax expense recorded on $51.6 million of pre-tax income. The effective income tax rate for the three months ended August 25, 2019 was 18.0% and reflects a $27.3 million income tax expense recorded on $151.6 million of pre-tax income. The increase in the effective tax rate in the quarter was primarily the result of a decline in the annual effective tax rate which was driven by a $7.1 million reduction in the tax benefit for losses carried back under the CARES Act. The Company initially recorded a tax benefit related to the CARES Act in the second quarter and such amount was updated during the three months ended August 23, 2020.
The effective income tax rate for the nine months ended August 23, 2020 was 24.0% and reflects a $57.9 million income tax benefit recorded on $241.7 million of pre-tax losses. The effective income tax rate for the nine months ended August 25, 2019 was 16.7% and reflects a $60.2 million income tax expense recorded on $359.4 million of pre-tax income. The increase in the effective tax rate was primarily driven by discrete tax benefits of $22.0 million attributable to employees exercising stock-based equity awards in 2020 and $1.9 million related to net operating loss carryback provisions under the CARES Act. These were partially offset by valuation allowance charges in 2020 of $17.7 million on deferred tax assets that are not more likely than not to be realized.